What’s a Life Worth and Who Gets to Decide?
In an ideal world, all patients would receive the best possible care regardless of cost. However, since wealth is unevenly distributed and there are...
Extinguishing Smoldering Myeloma?
For patients with smoldering myeloma – a precursor stage of multiple myeloma (MM) – the standard approach for years has been “watch and wait,”...
Is Chemoimmunotherapy for Upfront CLL on Life Support?
For years, standard of care first-line treatment for chronic lymphocytic leukemia (CLL) included the FCR (fludarabine, cyclophosphamide, rituximab) chemoimmunotherapy regimen. However, the past decade...
The High Price of Hemophilia
An estimated 20,000 people in the U.S. are living with the inherited bleeding disorder hemophilia, and more than 60% of them have moderate or...
Does Value Mean Doing Less?
Over the past decade, the concept of improving value by avoiding excessive care has taken center stage in discussions about the U.S. health care...
Calculating the Costs of Clinical Trials
Patients eager to contribute to research may not be fully aware of the hidden costs of trial participation
Of the three potential risks of participating...
Pediatric Hematology/Oncology: A Small Specialty Experiencing Big Changes
When Mona D. Shah, MD, MBA, finished her medical training in pediatric hematology/oncology in 2007, she estimated that most of her fellow trainees went...
Mainstreaming Alternative and Complementary Medicine
While some treatments for hematologic conditions such as sickle cell disease (SCD) and cancer, have been refined over time – increasing survival rates and...
Staging the Aging
Routine assessment of frailty can help clinicians tailor treatments and supportive care to an individual patient’s needs
Hematologic malignancies are often diseases of older adults...
The Other Opioid Epidemic
Federal crackdowns on opioid prescribing have shifted the crisis from overdoses to undertreatment
The United States is in the grip of an opioid epidemic that...
Current Issue
March 2020, Volume 6, Issue 4
This issue looks at how cost-effective analyses are used to inform health-care decisions, explains the latest maintenance of certification requirements, and more.
